Leonard Pinchuk, Ph.D., D.Sc.
Co-Founder, President, and CEO
Dr. Pinchuk is the Co-founder, President, and CEO of Innovia. As an inventor with a background in Chemistry, Engineering and Medicine, Dr.Pinchuk initiates and oversees all projects, and also provides substantial product and process development input. In addition, Dr. Pinchuk secures and manages the necessary funding for the companies and interacts with the biomedical community, including both industry and academia, to achieve Innovia’s goal of producing medical devices previously unattainable with conventional biomaterials.

Dr. Pinchuk is a world-renowned expert in the field of biomaterials and medical devices with over 80 patents in this area. His accomplishments include the invention of the nylon angioplasty balloon, which has now become the world’s most popular angioplasty balloon, marketed by Cordis Corporation, Boston Scientific Corporation (“BSC”), and Guidant Corporation; a flexible coronary stent; the family of polycarbonate urethane biomaterials for implantation applications; and polyurethane-based vascular grafts and stent-grafts, including the first modular bifurcated stent-graft for treating abdominal aortic aneurysms. Although some of these innovations have achieved very significant market acceptance, his most notable achievement has been the development of a novel family of biocompatible elastomeric copolymers that demonstrate superior biostability and compatibility in the vasculature as well as in other organs and tissues of the body. Specific formulations of this polymer have enabled the next generation of coronary stents, namely the Boston Scientific’s Taxus® Stent, where drugs can be released from these devices to inhibit restenosis.

He began his career at Cordis Corporation in 1983 where he became the Manager of their Applied Physics and Chemistry Group. In 1987, Dr. Pinchuk co-founded Corvita Corporation, with Dr. Norman Weldon, the former CEO of Cordis Corporation, where they pioneered the field of stent-grafts. Corvita completed a successful IPO on the NASDAQ in 1995 and was purchased the following year by Pfizer, Inc. Corvita was merged with Pfizer’s Schneider AG division which was purchased by BSC in 1998. After completing his contractual obligations with Pfizer and BSC, Dr. Pinchuk became a partner and the Chief Scientist at Syntheon LLC and helped to develop and improve a catheter-based treatment for varicose veins for VeinRx LLC. Dr. Pinchuk left Syntheon in May 2002, and with John B. Martin, Jr., founded Innovia LLC in October 2002.

Dr. Pinchuk received a B.S. degree in Chemistry from McGill University and a Ph.D., inter-departmental, in the fields of Chemistry, Engineering and Medicine from the University of Miami. In 2003, he was inducted into the University of Miami Iron Arrow Society (Highest Honors) and, in 2005, he received an honorary Doctor of Science degree from McGill.

Dr. Pinchuk is a member of various Boards, societies, and high level university committees. He has been published numerous times and frequently lectures throughout the world. Dr. Pinchuk's extensive work in the industry and the community has earned him many prestigious awards, including the 2008 Greater Miami Chamber of Commerce Healthcare Heroes Award.